Gene: PNPLA5
Official Full Name: patatin like domain 5, triacylglycerol lipaseprovided by HGNC
Gene Summary: This gene is a member of the patatin-like phospholipase family; its encoded protein has been shown to inhibit transacylation. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Apr 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22087 | PNPLA5 Knockout cell line (HCT 116) | Human | PNPLA5 | 1:2~1:4 | Negative | Online Inquiry |
PNPLA5 Gene Knockout Cell Lines are genetically engineered cellular platforms designed specifically for the study of the patatin-like phospholipase domain-containing protein 5 (PNPLA5). By using advanced CRISPR/Cas9 technology, these cell lines have been created to effectively disrupt the PNPLA5 gene, thus providing researchers with a powerful tool to investigate the functions and regulatory mechanisms involving this critical enzyme.
The primary function of PNPLA5 is linked to lipid metabolism, where it plays a pivotal role in the hydrolysis of triglycerides and phospholipids, which is essential for maintaining lipid homeostasis within cells. The knockout of the PNPLA5 gene allows for detailed exploration of its physiological and pathological roles, particularly in diseases such as metabolic syndrome, fatty liver disease, and neurodegenerative disorders. By simulating the loss of function in these cell lines, researchers can gain insights into the compensatory mechanisms that may come into play in cellular lipid handling, contributing to a better understanding of various lipid-related diseases.
The scientific importance of PNPLA5 Gene Knockout Cell Lines extends to both basic research and clinical settings; they enable the identification of new therapeutic targets, help in drug development, and may facilitate the understanding of drug responses in lipid metabolism-related conditions. Unlike conventional cell lines that do not mimic the absence of PNPLA5 function, these knockout variants present a unique advantage by providing a more accurate model for studying the consequences of gene disruption.
What sets our PNPLA5 Gene Knockout Cell Lines apart from other similar products on the market is our commitment to the integrity and reproducibility of our cell lines, backed by rigorous validation processes. This results in high-quality, consistent performance, ensuring that researchers can reliably reproduce results.
In conclusion, our PNPLA5 Gene Knockout Cell Lines offer a unique and invaluable resource for both researchers and clinicians aiming to deepen their understanding of lipid metabolism and its implications in human health. With a strong foundation in genetic engineering and a focus on quality, our company is dedicated to supporting the scientific community with cutting-edge biological products.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.